Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

TGTX holding history

TG Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings

Shares (Q2 2026)
222
Value
$12.2K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TGTX by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026222$12.2K<0.1%+67+43.2%AddedHolders
Q1 2026155$5.15K<0.1%+56+56.6%AddedHolders
Q4 202599$2.95K<0.1%00.0%UnchangedHolders
Q3 202599$3.58K<0.1%+30+43.5%AddedHolders
Q2 202569$2.48K<0.1%−48−41.0%ReducedHolders
Q1 2025117$4.61K<0.1%+27+30.0%AddedHolders
Q4 202490$2.71K<0.1%−9−9.1%ReducedHolders
Q3 202499$2.32K<0.1%+55+125.0%AddedHolders
Q2 202444$783<0.1%+44NewHolders
Q1 20240$00.0%−435−100.0%Sold outHolders
Q4 2023435$7.43K<0.1%00.0%UnchangedHolders
Q3 2023435$3.64K<0.1%00.0%UnchangedHolders
Q2 2023435$10.8K<0.1%00.0%UnchangedHolders
Q1 2023435$6.54K<0.1%00.0%UnchangedHolders
Q4 2022435$5.15K<0.1%00.0%UnchangedHolders
Q3 2022435$3.00K<0.1%00.0%UnchangedHolders
Q2 2022435$2.00K<0.1%+435NewHolders
Q1 20220$00.0%−528−100.0%Sold outHolders
Q4 2021528$10.0K<0.1%+478+956.0%AddedHolders
Q3 202150$2.00K<0.1%00.0%UnchangedHolders
Q2 202150$2.00K<0.1%−14−21.9%ReducedHolders
Q1 202164$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.